ABOUT TUESDAYS
Built for the day the peptides came back.
When the FDA banned 19 peptides in 2023, a generation of patients lost access overnight. Tuesdays was founded to be ready for the moment that ban was reversed — with the clinician network, pharmacy partners, and patient infrastructure already in place.
Our mission
Make the 12 reclassified peptides legally, safely, and affordably accessible to every American adult who could benefit — under the supervision of a real licensed clinician.
Our model
A monthly membership that bundles clinician care, lab monitoring, and pharmacy access. Pharmacy fulfillment is billed at-cost; we never mark up medications.
Leadership
Dr. Elena Park, MD
Chief Medical Officer
Internal medicine and longevity specialist. Former clinical lead at a top-3 telehealth platform.
Marcus Whittaker
Co-founder & CEO
Operator who built three healthcare marketplaces. Led federal-affairs strategy during the 2023 peptide ban.
Dr. Aisha Rahman, PharmD
Head of Pharmacy
503A compounding pharmacist and former PCAC public-comment author.